201 related articles for article (PubMed ID: 34176559)
21. Follicular Lymphoma: Refining Prognostic Models and Impact of Pod-24 in Clinical Outcomes.
Nogueira DS; Lage LAPC; Culler HF; Pereira J
Clin Lymphoma Myeloma Leuk; 2022 Feb; 22(2):67-75. PubMed ID: 34580043
[TBL] [Abstract][Full Text] [Related]
22. Patient-derived lymphoma spheroids integrating immune tumor microenvironment as preclinical follicular lymphoma models for personalized medicine.
Faria C; Gava F; Gravelle P; Valero JG; Dobaño-López C; Van Acker N; Quelen C; Jalowicki G; Morin R; Rossi C; Lagarde JM; Fournié JJ; Ysebaert L; Laurent C; Pérez-Galán P; Bezombes C
J Immunother Cancer; 2023 Oct; 11(10):. PubMed ID: 37899130
[TBL] [Abstract][Full Text] [Related]
23. Can histologic transformation of follicular lymphoma be predicted and prevented?
Kridel R; Sehn LH; Gascoyne RD
Blood; 2017 Jul; 130(3):258-266. PubMed ID: 28408460
[TBL] [Abstract][Full Text] [Related]
24. Follicular lymphoma: an update on diagnosis, prognosis, and management.
Mozas P; Sorigué M; López-Guillermo A
Med Clin (Barc); 2021 Nov; 157(9):440-448. PubMed ID: 34210513
[TBL] [Abstract][Full Text] [Related]
25. Refining the treatment of follicular lymphoma.
Buske C; Gisselbrecht C; Gribben J; Letai T; McLaughlin P; Wilson W
Leuk Lymphoma; 2008; 49 Suppl 1():18-26. PubMed ID: 18821429
[TBL] [Abstract][Full Text] [Related]
26. Mosunetuzumab and the emerging role of T-cell-engaging therapy in follicular lymphoma.
Matarasso S; Assouline S
Future Oncol; 2023 Oct; 19(31):2083-2101. PubMed ID: 37882361
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of tissue-infiltrating immune cells in tumor microenvironment of follicular lymphoma: A meta-analysis.
Xie M; Jiang Q; Zhao S; Zhao J; Ye X; Qian W
Int Immunopharmacol; 2020 Aug; 85():106684. PubMed ID: 32540726
[TBL] [Abstract][Full Text] [Related]
28. Indolent lymphoma: follicular lymphoma and the microenvironment-insights from gene expression profiling.
Rimsza LM; Jaramillo MC
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):163-8. PubMed ID: 25696850
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in follicular lymphoma: new tools to personalize risk.
Casulo C
Hematology Am Soc Hematol Educ Program; 2016 Dec; 2016(1):269-276. PubMed ID: 27913491
[TBL] [Abstract][Full Text] [Related]
30. Transformation of follicular lymphoma to diffuse large B-cell lymphoma may occur by divergent evolution from a common progenitor cell or by direct evolution from the follicular lymphoma clone.
Carlotti E; Wrench D; Matthews J; Iqbal S; Davies A; Norton A; Hart J; Lai R; Montoto S; Gribben JG; Lister TA; Fitzgibbon J
Blood; 2009 Apr; 113(15):3553-7. PubMed ID: 19202129
[TBL] [Abstract][Full Text] [Related]
31. Prognosis of follicular lymphomas.
Luminari S; Federico M
Hematol Oncol; 2006 Jun; 24(2):64-72. PubMed ID: 16514592
[TBL] [Abstract][Full Text] [Related]
32. Recommendations for Clinical Trial Development in Follicular Lymphoma.
Maddocks K; Barr PM; Cheson BD; Little RF; Baizer L; Kahl BS; Leonard JP; Fowler N; Gordon LI; Link BK; Friedberg JW; Ansell SM
J Natl Cancer Inst; 2017 Mar; 109(3):. PubMed ID: 28040699
[TBL] [Abstract][Full Text] [Related]
33. Pathogenesis of follicular lymphoma.
Lackraj T; Goswami R; Kridel R
Best Pract Res Clin Haematol; 2018 Mar; 31(1):2-14. PubMed ID: 29452662
[TBL] [Abstract][Full Text] [Related]
34. Histological Transformation and Progression in Follicular Lymphoma: A Clonal Evolution Study.
Kridel R; Chan FC; Mottok A; Boyle M; Farinha P; Tan K; Meissner B; Bashashati A; McPherson A; Roth A; Shumansky K; Yap D; Ben-Neriah S; Rosner J; Smith MA; Nielsen C; Giné E; Telenius A; Ennishi D; Mungall A; Moore R; Morin RD; Johnson NA; Sehn LH; Tousseyn T; Dogan A; Connors JM; Scott DW; Steidl C; Marra MA; Gascoyne RD; Shah SP
PLoS Med; 2016 Dec; 13(12):e1002197. PubMed ID: 27959929
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic targeting of microenvironment in follicular lymphoma.
Nowakowski GS; Ansell SM
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):169-73. PubMed ID: 25696851
[TBL] [Abstract][Full Text] [Related]
36. Systematic review of the potential of MicroRNAs in the management of patients with follicular lymphoma.
Arzuaga-Mendez J; Lopez-Santillan M; Garcia-Ruiz JC; Lopez-Lopez E; Martin-Guerrero I
Crit Rev Oncol Hematol; 2021 Mar; 159():103247. PubMed ID: 33515703
[TBL] [Abstract][Full Text] [Related]
37. Follicular Lymphoma Microenvironment Traits Associated with Event-Free Survival.
Tumedei MM; Piccinini F; Azzali I; Pirini F; Bravaccini S; De Matteis S; Agostinelli C; Castellani G; Zanoni M; Cortesi M; Vergani B; Leone BE; Righi S; Gazzola A; Casadei B; Gentilini D; Calzari L; Limarzi F; Sabattini E; Pession A; Tazzari M; Bertuzzi C
Int J Mol Sci; 2023 Jun; 24(12):. PubMed ID: 37373066
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathological analysis of immunohistochemical expression of immune checkpoint molecules in follicular lymphoma.
Yanagida E; Miyoshi H; Takeuchi M; Shimono J; Nakashima K; Yamada K; Kawamoto K; Moritsubo M; Shimasaki Y; Inoue K; Imamoto T; Furuta T; Kohno K; Ohshima K
Hematol Oncol; 2022 Oct; 40(4):530-540. PubMed ID: 35122292
[TBL] [Abstract][Full Text] [Related]
39. Diagnosis and management of follicular lymphoma: A comprehensive review.
Dada R
Eur J Haematol; 2019 Sep; 103(3):152-163. PubMed ID: 31270855
[TBL] [Abstract][Full Text] [Related]
40. Therapeutic approaches in patients with newly diagnosed follicular lymphoma.
Aguiar-Bujanda D; Blanco-Sánchez MJ; Jiménez-Gallego P; Mori-De Santiago M; Hernández-Sosa M; Galván-Ruíz S; Hernández-Sarmiento S; Saura-Grau S; Bohn-Sarmiento U
Future Oncol; 2014 Oct; 10(12):1967-80. PubMed ID: 25386813
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
